JNNP

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH REGISTER
[Advanced]

The most recent version of this article was published on 1 May 2008

J Neurol Neurosurg Psychiatry. Published Online First: 26 October 2007. doi:10.1136/jnnp.2007.125211
Copyright © 2007 by the BMJ Publishing Group Ltd.

This Article
Right arrow Full Text (Rapid PDF)
Right arrow All Versions of this Article:
jnnp.2007.125211v1
79/5/540    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Harloff, A.
Right arrow Articles by Markl, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Harloff, A.
Right arrow Articles by Markl, M.
Related Collections
Right arrowRelated Article

Original articles

Reliability of aortic MRI at 3Tesla in patients with acute cryptogenic stroke

Andreas Harloff 1*, Patrick Dudler 1, Alex Frydrychowicz 1, Christoph Strecker 1, Anna Lena Stroh 1, Annette Geibel 1, Cornelius Weiller 1, Andreas Hetzel 1, Jürgen Hennig 1 and Michael Markl 1

1 Albert-Ludwigs Universität Freiburg, Germany

* To whom correspondence should be addressed. E-mail: andreas.harloff{at}uniklinik-freiburg.de.

Accepted 11 October 2007


*  Abstract

Objectives To evaluate a new 3D MRI protocol for the reliable detection of aortic high-risk plaques compared to transesophageal echocardiography (TEE) and to test the reliability of additional MRI in stroke of undetermined etiology.

Methods 74 acute stroke patients were examined by both TEE and MRI at 3Tesla with special regard to aortic high-risk plaques (i.e., ≥4 mm, superimposed thrombi). ECG synchronized pre- and post-contrast T1-weighted 3D imaging (spatial resolution ~1mm3) covering the thoracic aorta was employed. In plaques ≥3 mm, additional 2D T2 imaging and time-resolved (CINE) imaging sequences were performed. Etiology of brain ischemia was classified according to modified TOAST criteria. Aortic high-risk embolic sources detected by MRI in patients with cryptogenic stroke were evaluated.

Results Differences in maximum aortic wall thickness (AWT) for TEE and MRI were not statistically significant for all aortic segments. The overall number of high-risk plaques detected by MRI (n=74) was substantially higher compared to TEE (n=47). Most noticeably, MRI identified aortic high-risk pathologies in 8/26 (30.8%) patients with cryptogenic stroke after standard diagnostics including TEE (n=2: dissection or thrombus; n=6: plaques ≥4 mm).

Conclusions Our results demonstrate the feasibility of this 3D MRI protocol for the reliable detection of aortic high-risk plaques in acute stroke patients. Due to the improved visualization of the aortic arch and the detection of additional embolic sources not seen by standard diagnostics this novel technique may become a valuable tool for future patients with cryptogenic stroke.


Keywords: Aorta, MRI, Plaque, Stroke, Transesophageal echocardiography


Related Article

Can aortic MRI be used instead of transoesophagal echocardiography in patients with ischaemic stroke?
Emmanuel Touzé
J. Neurol. Neurosurg. Psychiatry 2008 79: 489. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
J. Neurol. Neurosurg. PsychiatryHome page
E. Touze
Can aortic MRI be used instead of transoesophagal echocardiography in patients with ischaemic stroke?
J. Neurol. Neurosurg. Psychiatry, May 1, 2008; 79(5): 489 - 489.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2007 by the BMJ Publishing Group Ltd.